Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Every fifth case of multiple sclerosis is familial.]
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis.
Emotional dysfunctions in neurodegenerative diseases.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Transverse myelitis in a patient with primary antiphospholipid syndrome.
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.
Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis.
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Commentary: Never Underestimate the Power of Adenosine in Multiple Sclerosis.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Acute inflammatory myelopathies.
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis.
Snake bite-induced leucoencephalopathy.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
489
490
491
492
493
494
495
496
497
…
next ›
last »